FDA, NIH to lose key advocate with Mikulski retirement
This article was originally published in Scrip
Executive Summary
With the revelation on 2 March that yet another strong Capitol Hill supporter of the FDA and the National Institutes of Health (NIH) plans to soon depart Congress, the number of lawmakers that have long advocated for more funding for the agencies is increasingly dwindling.